The use of Bromocriptine in Ovulatory Infertility

Abstract

Attention has been drawn to the particularly low fertility rate associated wth those infertile women who have no detectable abnormality as judged by classical gynaecological investigation. A proportion of these patients, defined as having ovulatory infertility, were shown to have deficient progesterone production during the early part of the luteal phase although the luteal phase was of normal length. This group of patients has also been shown to have a high incidence of transient hyperprolactinaemia, most of which occurs during the luteal phase. Although the use of bromocriptine has been associated with successful conception in some patients with ovulatory infertility the response is as yet unpredictable and a precise regime has still to be defined.